Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 7816 AL 7830

Current advances and unmet needs in Alzheimer's disease trials for individuals with Down syndrome: Navigating new therapeutic frontiers

Barroeta I, Videla L, Carmona-Iragui M, Fortea J, Rafii MS.

Alzheimers Dement. 2025 Jun;21(6):e70258. doi: 10.1002/alz.70258.

Current and Emerging Pharmacological Approaches to Agitation in Alzheimer's Disease: A Narrative Review of New and Repurposed Therapies

Smoller C, Schiller E, Yamashita K, Silverglate BD, Grossberg GT.

Drugs. 2025 Nov;85(11):1391-1411. doi: 10.1007/s40265-025-02227-4. Epub 2025 Sep 6.

A critical review of brexpiprazole oral tablets as the first drug approved to treat agitation symptoms associated with dementia due to Alzheimer's disease

Zhong K, Cummings J.

Expert Rev Neurother. 2025 Jan;25(1):5-13. doi: 10.1080/14737175.2024.2407836. Epub 2024 Sep 29.

Behavioral and Psychological Symptoms (BPSD) in Alzheimer's Disease (AD): Development and Treatment

Lee HH, Chinnameyyappan A, Feldman OJ, Marotta G, Survilla K, Lanctôt KL.

Curr Top Behav Neurosci. 2025;69:245-273. doi: 10.1007/7854_2024_566.

A US-based practitioner's guide to diagnosis, evaluation, and evidence-based treatment of agitation in Alzheimer's dementia - recommendations of an expert, multispecialty advisory panel

Grossberg GT, Sanford A, Montano CB, Porsteinsson AP, Scanland S, Worz C, McMillian S, Atri A.

Postgrad Med. 2025 Aug;137(6):469-485. doi: 10.1080/00325481.2025.2517535. Epub 2025 Jun 17.

Stem cell-based therapeutic strategies for down syndrome and Alzheimer's disease

Hamadelseed O, Skutella T.

Stem Cell Res Ther. 2025 Aug 5;16(1):420. doi: 10.1186/s13287-025-04556-3.

Pharmacoutilization data-driven artificial intelligence-assisted diagnosis algorithm to improve the pharmacological treatment of pain and agitation in patients suffering from severe dementia

Scuteri D, Adornetto C, Greco G, Nicotera P, Bagetta G, Corasaniti MT.

Curr Opin Pharmacol. 2025 Oct;84:102563. doi: 10.1016/j.coph.2025.102563. Epub 2025 Jul 28.

Case Report: Care of the Agitated Emergency Department Patient With Alzheimer's Disease

McGillivray IL, Chen A, Normandin PA.

J Emerg Nurs. 2025 Jul;51(4):553-569. doi: 10.1016/j.jen.2025.04.002.

Auditory Hallucinations as the First Symptom of Alzheimer´s Disease - A Case Report

Husing T, Quante A.

Curr Alzheimer Res. 2025;22(11):864-867. doi: 10.2174/0115672050421769250929051818.

[Two cases of urinary retention in patients with Alzheimer's disease with agitation treated by acupuncture]

Zong G, Li R, Jiang Y, Chen Z, Yan S, Yi Z, Ren X, Jia B.

Zhongguo Zhen Jiu. 2025 Dec 12;45(12):1822-1824. doi: 10.13703/j.0255-2930.20250804-k0002. Epub 2025 Oct 20.

Protective Effects of Bifidobacterium Breve MCC1274 as a Novel Therapy for Alzheimer's Disease

Abdelhamid M, Counts SE, Zhou C, Hida H, Kim JI, Michikawa M, Jung CG.

Nutrients. 2025 Jan 31;17(3):558. doi: 10.3390/nu17030558.

A review of the application of exercise intervention on improving cognition in patients with Alzheimer's disease: mechanisms and clinical studies

Wang M, Hua Y, Bai Y.

Rev Neurosci. 2024 Jul 22;36(1):1-25. doi: 10.1515/revneuro-2024-0046. Print 2025 Jan 29.

Ferroptosis in Cognitive Impairment Associated with Diabetes and Alzheimer's Disease: Mechanistic Insights and New Therapeutic Opportunities

Ma M, Jing G, Tian Y, Yin R, Zhang M.

Mol Neurobiol. 2025 Feb;62(2):2435-2449. doi: 10.1007/s12035-024-04417-9. Epub 2024 Aug 7.

The Missing Link in Antiamyloid Therapy

Mandal PK, Maroon JC, Guha Roy R, Patira R, Gogniat MA, Sindhu B.

ACS Chem Neurosci. 2025 Feb 5;16(3):276-280. doi: 10.1021/acschemneuro.4c00825. Epub 2025 Jan 14.

[Pathophysiology and Clinical Presentation of Amyloid-Related Imaging Abnormality Induced by Anti-Amyloid-β Antibody Lecanemab]

Tomimoto H, Matsumoto M, Shiina H, Saeki Y, Niidome T, Nakamura Y.

Brain Nerve. 2025 Feb;77(2):175-187. doi: 10.11477/mf.188160960770020175.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias